Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.caratherapeutics.com
Stamford, CT, USA
Founded in 2004Inaccurate data? Flag it here.
Open jobs at Cara Therapeutics